Schering-Plough
Schering-Plough
Schering-Plough (pronounced: SH-air-ing PLOW) was an American pharmaceutical company. It was founded in 1851 by Ernst Christian Friedrich Schering as Schering AG in Germany. In 1971, the Schering Corporation merged with Plough (founded by Abe Plough in Memphis, Tennessee in 1908) to form Schering-Plough.
History
Schering AG, a German pharmaceutical company, was founded in 1851. The American pharmaceutical company, Plough, was founded in 1908. The two companies merged in 1971 to form Schering-Plough. The company was bought by Merck & Co. in 2009.
Products
Schering-Plough produced several pharmaceutical drugs, most notably the allergy drugs Claritin and Nasonex, the hepatitis C drug PegIntron, and the brain tumor drug Temodar.
Merger with Merck & Co.
In 2009, Schering-Plough merged with Merck & Co., another American pharmaceutical company. The merger was completed in November of that year. The combined company retained the Merck name.
See Also
External links
- Medical encyclopedia article on Schering-Plough
- Wikipedia's article - Schering-Plough
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski